Narcolepsy in childhood

Sleep Medicine Reviews

Volumn 13, Issue 2, 2009, Pages 169-180

  Nevsimalova, Sona ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adolescents; Atypical features; Childhood narcolepsy; Diagnostic criteria at different ages; Infants and toddlers; School age; Secondary cases; Treatment and management

Indexed keywords

ATOMOXETINE; CLOMIPRAMINE; FLUOXETINE; IMMUNOGLOBULIN; METHYLPHENIDATE; MODAFINIL; OREXIN; OXYBATE SODIUM; PEMOLINE; STEROID; VENLAFAXINE;

ACTIMETRY; BEHAVIOR CHANGE; CATAPLEXY; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DAYTIME SOMNOLENCE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROOCULOGRAM; EXERCISE; GENETIC ANALYSIS; HLA SYSTEM; HUMAN; HYPNAGOGIC HALLUCINATION; LIVER TOXICITY; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASOMNIA; PEDIATRICS; PERSONALITY DISORDER; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRECOCIOUS PUBERTY; REVIEW;

ADOLESCENT; CATALEPSY; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; INFANT; NARCOLEPSY; POLYSOMNOGRAPHY;

EID: 61449136692     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2008.04.007     Document Type: Review

References (76)

1. International classification of sleep disorders. Diagnostic and coding manual. 2nd ed. (2005), American Academy of Sleep Medicine, Westchester, IL, USA
2. Nevsimalova S. Narcolepsy in children and adolescents. In: Bassetti C., Billiard M., and Mignot E. (Eds). Narcolepsy and hypersomnia (2007), Informa Healthcare, USA 67-75
3. McKenna C., and McNicholas F. Childhood onset narcolepsy. A case report. Eur Child Adolesc Psychiatry 12 (2003) 43-47
4. Guilleminault C., and Pelayo R. Narcolepsy in prepubertal children. Ann Neurol 43 (1998) 135-142
5. Morrish E., King M.A., Smith I.E., and Shneerson J.M. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 5 (2004) 37-41
6. Ohayon M.M., Priest R.G., Zulley J., Smirne S., and Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 58 (2002) 1826-1833
7. Silber M.H., Krahn L.E., Olson E.J., and Pankratz V.S. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 25 (2002) 197-202
8. Dauvilliers Y., Montplaisir J., Molinari N., Carlander B., Ondze B., Besset A., et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 57 (2001) 2029-2033
9. Challamel M.J., Mazzola M.E., Nevšímalová S., Cannard C., Louis J., Revol S., et al. Sleep 17 Suppl. 8 (1994) S17-S20
10. Nevsimalova S., Mignot E., Šonka K., and Arrigoni J.L. Familial aspects of narcolepsy-cataplexy in the Czech Republic. Sleep 20 (1997) 1021-1026
11. Ohayon M.M., Ferini-Strambi L., Plazzi G., Smirne S., Castronovo V., et al. Frequency of narcolepsy symptoms and other sleep disorders in narcoleptic patients and their first-degree relatives. J Sleep Res 14 (2005) 437-445
12. Kadotani H., Faraco J., and Mignot E. Genetic studies in the sleep disorder narcolepsy. Genome Res 8 (September 5, 2007) 427-434. www.genome.org
13. Dauvilliers Y., Gosselin A., Paquet J., Touchon J., Billiard M., and Montplaisir J. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology 62 (2004) 46-50
14. Guilleminault C., Mignot E., and Partinen M. Narcolepsy diagnosis and epidemiology. Controversies in the diagnosis of narcolepsy. Sleep 17 (1994) S1-S6
15. Young D., Zorick F., Witting R., Roehrs T., and Roth T. Narcolepsy in a pediatric population. Am J Dis Child 142 (1988) 210-213
16. Mignot E. Sleep, sleep disorder and hypocretin (orexin). Sleep Med 5 Suppl. 1 (2004) S2-S8
17. Lecendreux M., Maret S., Bassetti C., Mouren M.C., and Taffin M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old-boy. Letter to the Editor. J Sleep Res 12 (2003) 1-2
18. Dauvilliers Y., Carlander B., River F., Touchon J., and Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 56 (2004) 905-908
19. Dauvillier Y. Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Letter, American Neurological Association. Wiley-Liss, Inc., through Wiley Subscription Service; 2006.
20. Hecht M., Lin L., Kushida C.A., Umetsu D.T., Taheri S., Einen M., et al. Immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin deficiency/narcolepsy. Sleep 26 (2003) 809-810
21. Nishino S. Clinical and neurobiological aspects of narcolepsy. Sleep Med 8 (2007) 373-399
22. Mignot E. Narcolepsy: pharmacology, pathophysiology and genetics. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 4th ed. (2005), Elsevier Sounders, Philadelphia 761-779
23. Kanbayashi T., Yano T., Ishiguro H., Kawanishi K., Chiba S., Aizawa R., et al. Hypocretin (orexin) levels in human lumbar CSF in different age groups: infants to elderly persons. Sleep 25 (2002) 337-339
24. Tsukamoto H., Ishikawsa T., Fujii Y., Fukumitu M., Sugai K., and Kanbayashi T. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy. Neuropediatrics 33 (2002) 51-52
25. Kubota H., Kanbayashi T., Tanabe Y., Ito M., Takanashi J., Kohno Y., et al. Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children. Sleep 26 (2003) 555-557
26. Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G.J., Vankova J., et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355 (2000) 39-40
27. Gerashchenko D., Murillo-Rodrigues E., Lin L., Xu M., Hallett L., Nishino S., et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184 (2003) 1010-1016
28. Billiard M., and Orellana C. Environmental factors in narcolepsy. In: Bassetti C., Billiard M., and Mignot E. (Eds). Narcolepsy and hypersomnia (2007), Informa Healthcare, USA 443-450
29. Guilleminault C., and Pelayo R. Narcolepsy in children. A practical guide to its diagnosis, treatment and follow-up. Paediatr Drug 2 (2000) 1-9
30. Hood B.M., and Harbord M.G. Paediatric narcolepsy: complexities of diagnosis. J Paediatr Child Health 38 (2002) 618-621
31. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6 (2000) 991-997
32. Nevsimalova S., Vankova J., Sonka K., Faraco J., Rogers W., Overeem S., et al. Hypocretin (orexin) deficiency in narcolepsy-cataplexy (in Czech). Sb Lek 101 (2000) 381-386
33. Nevsimalova S., Roth B., Zouhar A., and Zemanova H. The occurrence of narcolepsy-cataplexy and periodic hypersomnia in early childhood. In: Koella W.P., Obal F., Schulz H., and Wisser P. (Eds). Sleep '86 (1988), Gustav Fisher Verlag, Stuttgart, New York 399-401
34. Hayes D. Narcolepsy with cataplexy in early childhood. Clin Pediatr 45 (2006) 361-383
35. Sharp S.J., and D'Cruz O.F. Narcolepsy in a 12 months old boy. J Child Neurol 16 (2001) 145-146
36. Winter E., Prengergast M., and Green A. Narcolepsy in a 2-year-old boy. Dev Med Child Neurol 38 (1996) 356-370
37. Lent C., and Somajni F. Narcolepsy in an 8-year old boy: neurologic and psychiatric study. J Child Neurol 13 (1998) 405-407
38. Witmans M.B., and Kirk V.G. Infancy onset of symptoms of narcolepsy in a child. Clin Pediatr 41 (2002) 609-612
39. Iglowstein I., Jenni O., Molinari L., and Largo R. Sleep duration from infancy to adolescence: reference values and generational trends. Pediatrics 111 (2003) 302-307
40. Nevsimalova S., Pretl M., Vankova J., Blazejova K., and Sonka K. Narcolepsy in children and adolescents. In: Evrard P., Richelme C., and Tardieu M. (Eds). 3rd EPNS Congress (1999), Monduzzi, Bologna 73-77
41. Challamel M.J. Hypersomnia in children. In: Billiard M. (Ed). Sleep - physiology, investigation and medicine (2003), Kluwer Academic/Plenum Publishers, New York 457-468
42. Wise M.S. Childhood narcolepsy. Neurology 50 Suppl. 1 (1998) S37-S42
43. Nevsimalova S., Prihodova I., Kemlink D., Ling L., and Mignot E. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy. Sleep Med 8 (2007) 784-786
44. Nevsimalova S., Vankova S., Pretl M., and Bruck D. Narcolepsy in children and adolescents - clinical and psychosocial aspects (in Czech). Ces Slov Neurol Neurochir 65 (2002) 169-174
45. Kotagal S. Narcolepsy in childhood. In: Sheldon S.H., Ferber R., and Kryger M.H. (Eds). Practices and principles of pediatric sleep medicine (2005), Elsevier Saunders 171-182
46. Stores G., Montgomery P., and Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics 118 (2006) 1116-1123
47. Khatami R., Birkmann S., and Bassetti C. Amygdala dysfunction in narcolepsy-cataplexy. J Sleep Res 16 (2007) 226-229
48. Tucci V, Plazzi G. Cataplexy: an affair of pleasure or an unpleasant affair? Neurosci Lett 2009;450:90-91.
49. Dahl R.E., Holttum J., and Trubnick L. A clinical picture of child and adolescent narcolepsy. J Am Acad Child Adolesc Psychiatry 33 (1994) 834-841
50. Kotagal S., Krahn L.E., and Slocumb N. A putative link between childhood narcolepsy and obesity. Sleep Med 5 (2004) 147-150
51. Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G.J., Vankova J., et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50 (2001) 381-388
52. Arnulf I., Lin L., Zhang J., Russel J., Ripley E.M., et al. CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?. Sleep 29 (2006) 1017-1024
53. Chabas D., Foulon C., Gonzales J., Nasr M., Caen O.L., Willer J.C., et al. Eating disorder and metabolism in narcoleptic patients. Sleep 30 (2007) 1267-1273
54. Ferguson A.V., and Samson W.K. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic functions. Front Neuroendocrinol 24 (2003) 141-150
55. Jaszberenyi M., Bujdoso E., Pataki I., and Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 12 (2000) 1174-1178
56. Plazzi G., Parmeggiani A., Mignot E., Lin L., Scano M.C., Posar A., et al. Narcolepsy-cataplexy associated with precocious puberty. Neurology 66 (2006) 1577-1579
57. Nishino S., and Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implication in the hypothalamic hypocretin/orexin system. Sleep Med Rev 9 (2005) 269-310
58. Marcus C.L., Trescher W.H., Halbower A.C., and Lutz J. Secondary narcolepsy in children with brain tumors. Sleep 25 (2002) 435-439
59. Vankova J., Stepanova I., Jech R., Elleder M., Ling L., Mignot E., et al. Sleep disturbance and hypocretin deficiency in Niemann-Pick disease type C. Sleep 26 (2003) 427-430
60. Smit L.S., Lammers G.L., and Catsman-Berrevoets C.E. Cataplexy leading to the diagnosis of Niemann-Pick disease. Ped Neurol 35 (2006) 82-84
61. Carskadon M., and Rechtschaffen A. Monitoring and staging human sleep. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 4th ed. (2005), Elsevier Sounders, Philadelphia 1359-1377
62. Kotagal S., Hartse K.M., and Walch J.K. Characteristics of narcolepsy in pre-teenaged children. Pediatrics 85 (1990) 205-209
63. Carskadon M.A., Dement W.C., Mitler M.M., Roth T., Westbrook P., and Keeenan S. Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep 9 (1986) 519-524
64. Carskadon M.A., Harvey K., Duke P., Anders T.F., Litt I.F., and Dement W.C. Pubertal change in daytime sleepiness. Sleep 3 (1980) 453-460
65. Kotagal S., and Goulding P.M. The laboratory assessment of daytime sleepiness in childhood. J Clin Neurophysiol 13 (1996) 208-218
66. Huang Y.S., Tafti M., and Guilleminault C. Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients. Sleep Med 7 (2006) 454-457
67. Pollmacher T., Dalal M.A., and Schuld A. Immunoendocrine abnormalities in narcolepsy. Sleep Med Clin 2 (2007) 293-302
68. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., et al. The role of cerebrospinal fluid hypocretin in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59 (2002) 1553-1562
69. Nelson G.B., and Hahn J.S. Stimulus-induced drop episodes in Coffin-Lowry syndrome. Pediatrics 111 (2003) e197-e202
70. Stephenson J.B., Hoffman M.C., Russell A.J., Falconer J., Beach R.C., Tolmie J.L., et al. The movement disorders of Coffin-Lowry syndrome. Brain Dev 27 (2005) 108-113
71. Nevšímalová S. Differential diagnosis of narcolepsy and other hypersomnia. Vigilia-Sueno 10 Suppl. (1998) S85-S96
72. Krahn L.E., Hansen M.R., and Shepard J.W. Pseudocataplexy. Psychosomatics 42 (2001) 356-358
73. Krahn L.E. Reevaluating spells initially identified as cataplexy. Sleep Med 6 (2005) 537-542
74. Ivanenko A., Tauman R., and Gozal D. Modafinil in the treatment of excessive daytime sleepiness in children. Sleep Med 4 (2003) 579-582
75. Murali H., and Kotagal S. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Sleep 29 (2006) 1020-1025
76. Guilleminault C., and Fromherz S. Narcolepsy: diagnosis and management. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 4th ed. (2005), Elsevier Sounders, Philadelphia 780-790